Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries
- PMID: 33739486
- DOI: 10.1111/add.15483
Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries
Abstract
Background and aim: New Zealand has recently legalized medicinal cannabis and has explored the possibility of legalizing large-scale recreational cannabis supply. In the process, concerns have emerged regarding whether corporations involved in the large-scale production and sale of legalized cannabis will invest in tactics of influence with policymakers and the public. This paper aimed to examine the various ways a legalized cannabis industry could seek to influence governments and the public in the New Zealand reform context.
Method: Based on the study of industry tactics with alcohol, tobacco and gambling, we applied a three-chain model of industry influence that breaks tactics into the 'public good', 'knowledge' and 'political' chains.
Results: Exploratory analysis of the nascent cannabis industry's activity in New Zealand provided signs of industry influence strategies related to all three chains. The medicinal cannabis industry has associated the establishment of a legal cannabis sector with regional economic development and employment, supported lobbying for recreational law reform, funded NGOs involved in lobbying for law reform, established research partnerships with universities, invited ex-politicians on advisory boards, and participated in government public sector partnerships.
Conclusion: There is emerging evidence that the legal cannabis industry is using strategies to influence the regulatory environment in New Zealand.
Keywords: Cannabis; commercial determinants; conflicts of interest; drug policy; industry influence; legalization; marijuana; regulatory capture.
© 2021 Society for the Study of Addiction.
Comment in
-
We can't rely upon monitoring by researchers and civil society to prevent cannabis industry influence-a global response is needed.Addiction. 2021 Nov;116(11):2948-2950. doi: 10.1111/add.15575. Epub 2021 May 28. Addiction. 2021. PMID: 34048105 No abstract available.
-
Think big about developing the science.Addiction. 2021 Nov;116(11):2947-2948. doi: 10.1111/add.15568. Epub 2021 May 31. Addiction. 2021. PMID: 34060152 Free PMC article. No abstract available.
-
Cannabis chains of influence from a US perspective.Addiction. 2021 Nov;116(11):2950-2951. doi: 10.1111/add.15577. Epub 2021 Jun 9. Addiction. 2021. PMID: 34105204 No abstract available.
-
How does the influence of the cannabis industry differ from that of alcohol and tobacco?Addiction. 2021 Nov;116(11):2951-2952. doi: 10.1111/add.15637. Epub 2021 Jul 30. Addiction. 2021. PMID: 34327753 No abstract available.
References
-
- Decorte T., Lenton S., Wilkins C., editors. Legalizing Cannabis: Experiences, Lessons and Scenarios. London: Routledge; 2020.
-
- McGinty E., Niederdeppe J., Heley K., Barry C. Public perceptions of arguments supporting and opposing recreational marijuana legalization. Prev Med 2017; 99: 80-86.
-
- Kilmer B., Neel E. Being thoughtful about cannabis legalization and social equity. World Psychiatry 2020; 19: 194-195.
-
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Monitoring and evaluating changes in cannabis policies: Insights from the Americas. Luxembourg: Publications Office of the European Union; 2020 EMCDDA Technical Report.
-
- Hall W., Stjepanović D., Caulkins J., Lynskey M., Leung J., Campbell G., et al. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet 2019; 394: 1580-1590.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
